The Tendency of Traditional Chinese Medicine to Internationalism Is the Question of Pricing Right

When TCM goes international, it is necessary to strengthen the study of pharmacoeconomics. At the “Seminar on Empirical Pharmaceutical Economics Research and Development of Chinese Medicinal Industry” organized by the Department of Science and Technology of the State Administration of Traditional Chinese Medicine, if it is possible to introduce pharmacoeconomics in the clinical research work of TCM The evaluation indicators may make the puzzles that have tangled us for decades clear and bright, and can also promote Chinese medicine to go abroad and go global.

As the Chinese traditional Chinese medicine, due to the complexity of its components, components, and the inaccuracy of evaluation results, the degree of progress in the evaluation of pharmacoeconomics of traditional Chinese medicine is not optimistic. Chinese medicine has to go international, and it actually involves the issue of pricing rights. The pricing power is a very important issue for TCM to expand its international market, generate economic benefits, and contribute to the country's economic interests.

Chinese medicine research faces several challenges: First, Chinese medicine hospitals increasingly use Western medicine guidelines. Therefore, Chinese medicine evaluation needs not only a head-to-head comparison, but also the need to evaluate the efficacy changes of traditional Chinese medicines based on Western medicine. Therefore, it is necessary to do pharmacoeconomic evaluation. After conducting long-term, extensive, and in-depth studies on a series of problems and challenges facing traditional Chinese medicines in the evaluation of pharmacoeconomics, they jointly developed the “draft of traditional Chinese medicine drug research” (draft).

In the current medical environment, Chinese medicine is going international. Given that most chronic diseases are treated with complex interventions, and treatment options and treatment pathways are increasingly referring to various treatment guidelines at home and abroad, the design and implementation of traditional Chinese medicine drug economics evaluation are facing Many realistic challenges need to consider more factors and the design is more complex. At the design stage, we must fully research and evaluate the impact of a large number of clinical practical problems and the differences in medical and health policies across the country. The promulgation of the "Standard for the Study of Pharmacoeconomics of Chinese Materia Medica" (draft) provides a good reference for future research.